Clinical and pharmacoeconomic aspects of omalizumab: a 4-year follow-up
F Menzella, N Facciolongo, R Piro… - Therapeutic …, 2012 - journals.sagepub.com
Objectives: The aim of this study was to assess the stability of the effectiveness of
omalizumab as add-on treatment in 11 patients with severe persistent allergic asthma …
omalizumab as add-on treatment in 11 patients with severe persistent allergic asthma …
Clinical and pharmacoeconomic aspects of omalizumab: a 4-year follow-up.
F Menzella, N Facciolongo, R Piro… - Therapeutic …, 2012 - search.ebscohost.com
Objectives: The aim of this study was to assess the stability of the effectiveness of
omalizumab as add-on treatment in 11 patients with severe persistent allergic asthma …
omalizumab as add-on treatment in 11 patients with severe persistent allergic asthma …
Clinical and pharmacoeconomic aspects of omalizumab: a 4-year follow-up.
F Menzella, N Facciolongo, R Piro… - Therapeutic …, 2012 - europepmc.org
Objectives The aim of this study was to assess the stability of the effectiveness of
omalizumab as add-on treatment in 11 patients with severe persistent allergic asthma …
omalizumab as add-on treatment in 11 patients with severe persistent allergic asthma …
Clinical and pharmacoeconomic aspects of omalizumab: a 4-year follow-up
F Menzella, N Facciolongo, R Piro… - Therapeutic …, 2012 - pubmed.ncbi.nlm.nih.gov
Objectives The aim of this study was to assess the stability of the effectiveness of
omalizumab as add-on treatment in 11 patients with severe persistent allergic asthma …
omalizumab as add-on treatment in 11 patients with severe persistent allergic asthma …